Analysis of postmarketing safety data for proton-pump inhibitors reveals increased propensity for renal injury, electrolyte abnormalities, and nephrolithiasis | Scientific Reports
Medication Monitor: The Dark Side of Proton Pump Inhibitors - Today's Geriatric Medicine